A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2

NCT01596725 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
333
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novavax

Collaborators